These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 19324023)
21. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827 [TBL] [Abstract][Full Text] [Related]
22. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen. Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722 [TBL] [Abstract][Full Text] [Related]
23. Androgen receptor in the Mongolian gerbil ventral prostate: evaluation during different phases of postnatal development and following androgen blockage. Cordeiro RS; Scarano WR; Campos SG; Santos FC; Vilamaior PS; Góes RM; Taboga SR Micron; 2008 Dec; 39(8):1312-24. PubMed ID: 18394909 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of a rapid in vitro androgen receptor transcriptional activation assay using AR-EcoScreen cells. Araki N; Ohno K; Takeyoshi M; Iida M Toxicol In Vitro; 2005 Apr; 19(3):335-52. PubMed ID: 15713541 [TBL] [Abstract][Full Text] [Related]
25. 4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor. Wakabayashi K; Imai K; Miyachi H; Hashimoto Y; Tanatani A Bioorg Med Chem; 2008 Jul; 16(14):6799-812. PubMed ID: 18571420 [TBL] [Abstract][Full Text] [Related]
26. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Liu J; Shimizu K; Konishi F; Kumamoto S; Kondo R Bioorg Med Chem; 2007 Jul; 15(14):4966-72. PubMed ID: 17499997 [TBL] [Abstract][Full Text] [Related]
27. [Androgen receptor isoforms expression and its novel cDNA cloning in human prostate]. Xia S; Wang Y; Tang X Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1500-3. PubMed ID: 16200775 [TBL] [Abstract][Full Text] [Related]
28. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. Roy P; Salminen H; Koskimies P; Simola J; Smeds A; Saukko P; Huhtaniemi IT J Steroid Biochem Mol Biol; 2004 Feb; 88(2):157-66. PubMed ID: 15084347 [TBL] [Abstract][Full Text] [Related]
29. Endocrine toxicology--contributions of in vitro methods to the 3R concept. Freyberger A; Scholz G ALTEX; 2004; 21 Suppl 3():20-7. PubMed ID: 15057405 [TBL] [Abstract][Full Text] [Related]
30. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia. Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328 [TBL] [Abstract][Full Text] [Related]
31. Screening for androgen receptor activities in 253 industrial chemicals by in vitro reporter gene assays using AR-EcoScreen cells. Araki N; Ohno K; Nakai M; Takeyoshi M; Iida M Toxicol In Vitro; 2005 Sep; 19(6):831-42. PubMed ID: 15950433 [TBL] [Abstract][Full Text] [Related]
32. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer. Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593 [TBL] [Abstract][Full Text] [Related]
33. CDC25A functions as a novel Ar corepressor in prostate cancer cells. Chiu YT; Han HY; Leung SC; Yuen HF; Chau CW; Guo Z; Qiu Y; Chan KW; Wang X; Wong YC; Ling MT J Mol Biol; 2009 Jan; 385(2):446-56. PubMed ID: 19013180 [TBL] [Abstract][Full Text] [Related]
34. Selective androgen receptor modulators: in pursuit of tissue-selective androgens. Omwancha J; Brown TR Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931 [TBL] [Abstract][Full Text] [Related]
35. Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo. Yang S; Jiang M; Grabowska MM; Li J; Connelly ZM; Zhang J; Hayward SW; Cates JM; Han G; Yu X Oncotarget; 2016 Oct; 7(43):70404-70419. PubMed ID: 27611945 [TBL] [Abstract][Full Text] [Related]
36. Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer. Chu JH; Yu S; Hayward SW; Chan FL Prostate; 2009 Mar; 69(4):428-42. PubMed ID: 19107869 [TBL] [Abstract][Full Text] [Related]
37. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats. Wang C; Du X; Yang R; Liu J; Xu D; Shi J; Chen L; Shao R; Fan G; Gao X; Tian G; Zhu Y; Zhang J J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459 [TBL] [Abstract][Full Text] [Related]
38. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways. Vis AN; Schröder FH BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559 [TBL] [Abstract][Full Text] [Related]
39. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function. Zolochevska O; Figueiredo ML Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of androgen receptor transcriptional activities of some pesticides in vitro. Xu LC; Liu L; Ren XM; Zhang MR; Cong N; Xu AQ; Shao JH Toxicology; 2008 Jan; 243(1-2):59-65. PubMed ID: 17980950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]